Rheumatology

RITUXAN

RITUXAN (rituximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells.
Infusion or injection therapy referral
What it treats Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA, Wegener's Granulomatosis), Microscopic Polyangiitis (MPA), Moderate to severe Pemphigus Vulgaris
Prescribed by Oncologists, Rheumatologists & Dermatologists
How it’s administered Intravenous (IV) infusion
Frequency Varies depending on the condition being treated.
Length of treatment Varies depending on the condition being treated.

About This Therapy

RITUXAN (rituximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, thereby helping to protect healthy cells from damage. Specifically, it is a CD20-directed cytolytic antibody used for a variety of lymphomas, leukemias, and inflammatory conditions. Although RITUXAN may be used to treat cancer, it is not chemotherapy.

Other biosimilar brands of Rituximab include RUXIENCE (rituximab-pvvr) and TRUXIMA (rituximab-abbs).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

RITUXAN REFERRAL FORM

RITUXAN REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.

Ready to refer a patient for RITUXAN

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.